Global Diet Pills Market Size, Share and Trends Analysis Report, By Product Type (Prescription Based Drugs, Over the Counter Drugs, and Herbal Supplements), By Application (Metabolism Raising Pills, Fat Blocking Pills, and Appetite Controlling Pills), and By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) Forecast (2022-2028)

The diet pills market is anticipated to grow at a significant CAGR of 9.8% during the forecast period (2022-2028). The major factors driving the growth of the global diet pills market are the rising prevalence of obesity and obesity-related chronic diseases as it is a severe health risks that can lead to a variety of additional issues. In the US alone, one in every three adults is obese. Diet pills are drugs that are used in conjunction with diet and exercise to help people lose weight and thin down. Moreover, the growing awareness of fitness is another factor fueling the growth of the market. Diet tablets can help a person’s health by reducing blood sugar, blood pressure, and triglycerides by loosening their weight. These diet pills operate by improving your body’s metabolism, preventing fat absorption, increasing fat burning, and suppressing your hunger.
The global diet pills market is segmented based on product type, application, and distribution channel. Based on type, the market is sub-segmented into prescription-based drugs, over the counter drugs, and herbal supplements. Among these types, the prescription-based drugs segment is expected to propel the growth of the market due to the efficiency of these tablets in the treatment of obesity. Based on application, the market is sub-segmented into metabolism raising pills, fat blocking pills, and appetite-controlling pills. Based on the distribution channel, the market is sub-segmented into hospital pharmacy, retail pharmacy, and online pharmacy.
The market players are also contributing significantly to the market growth by adopting various strategies, including mergers acquisitions, geographical expansion, partnerships, collaborations, and new product launches, to stay competitive in the market. For instance, in April 2019, Gelesis and Wolfson Berg Ltd. announced that their weight reduction hydrogel tablet, dubbed Plenity, had received FDA approval. Plenity is approved for usage in individuals who are overweight or obese. It is a medication for individuals with a BMI of 25-40 kg/m2. As there is no time limit on how long the diet tablet may be taken for weight loss, thus, it can be used by persons with and without comorbidities like hypertension, type-2 diabetes, or dyslipidemia.

Market Coverage
The market number available for – 2021-2028
Base year- 2021
Forecast period- 2022-2028

Segment Covered-
By Type
By Application
By Distribution Channel

Regions Covered-
North America
Europe
Asia-Pacific
Rest of the World

Competitive Landscape-
Zoller Laboratories Ltd., Herbalife Ltd. Mylan NV, Aurobindo Pharma Ltd., Lupin Pharmaceuticals Inc., and Sun Pharmaceutical Industries Ltd. among others.

Key questions addressed by the report
What is the market growth rate?
Which segment and region dominate the market in the base year?
Which segment and region will project the fastest growth in the market?
How has COVID-19 impacted the market?
Deviation from the pre-COVID-19 forecast
Most affected region and segment
Who is the leader in the market?
How players are addressing challenges to sustain growth?
Where is the investment opportunity?

Global Diet Pills Market Report by Segment
By Type
Prescription Based Drugs
Over the Counter Drugs
Herbal Supplements

By Application
Metabolism Raising Pills
Fat Blocking Pills
Appetite Controlling Pills

By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy